Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)—a trial by Asian Myeloma Network (NCT03695744).
Saved in:
| Title: | Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)—a trial by Asian Myeloma Network (NCT03695744). |
|---|---|
| Authors: | Tan, Melinda S. Y.1,2 (AUTHOR), Nagarajan, Chandramouli1,2 (AUTHOR) chandramouli.nagarajan@singhealth.com.sg, Ooi, Melissa3 (AUTHOR), De Mel, Sanjay3 (AUTHOR), Binte Hashim, Nur Shahidah1 (AUTHOR), Li, Xinhua4 (AUTHOR), Chua, Ashlett1 (AUTHOR), Pokharkar, Yogesh4 (AUTHOR), Tso, Allison5 (AUTHOR), Awasthi, Neha4 (AUTHOR), Durie, Brian6 (AUTHOR), Chen, Yunxin1,2 (AUTHOR), Chng, Wee Joo3 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Feb2026, Vol. 67 Issue 3, p600-607. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2025.2602050 |
